OpportunityTitle: Investigator-Initiated Clinical Sequencing Research (R01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: The purpose of this funding opportunity announcement is to broaden the NHGRI investigator-initiated portfolio in genomic medicine by stimulating research that informs the implementation of genome sequencing in clinical care. This includes, but is not limited to, studies of whether and how clinical genome sequencing impacts disease diagnosis and treatment, studies that address current barriers to the implementation of clinical genome sequencing, and studies of approaches to improve the identification and interpretation of genomic variants for dissemination in clinical settings.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;